Philips Grand Challenge

Do you have a solution for sleep or respiratory health?
Calling all researchers with great ideas!

Life Sciences PA and Philips have partnered together to bring you The Philips Grand Challenge. The Grand Challenge is a unique opportunity to share your research aimed at solving sleep and respiratory problems and connect with Philips.

Areas of focus:
Sleep

Sleep is critically important for performance as well as learning and development. Inadequate sleep quantity, and in many cases, quality, can negatively impact decision making, immune function, alertness and physical performance.

Respiratory
Respiratory health can be a limiting factor for performance. Although the capacity of the healthy respiratory system in most humans is sufficient to handle the demands associated with ventilation and gas exchange, any disease/disorder impeding proper breathing and respiratory health can have a compromising effect on one’s ability to perform.

Award
(3) Three winners will be chosen and an award of $5,000 will be provided to each winner. The funding should be used to reduce technical and market risk associated with the innovation, moving it closer to commercialization.

(8) Eight teams will be chosen to present at Life Sciences Future in Philadelphia, PA on October 29-30, 2018, where the winners will be determined.

The three winners will also be invited to present their proposal to Philips Sleep & Respiratory Care Leadership in Pittsburgh, PA (date to be determined).

 
About Us
Philips is a global leader in health technology with more than 40 years of leadership in sleep apnea management, oxygen therapy, noninvasive ventilation and respiratory drug delivery. Philips strives to create meaningful innovations that improve people’s lives,

Problem Statement
Example areas of innovation topics of interest to Philips that would fit the challenge scope:

Post-Traumatic Stress Disorder, Mild Traumatic Brain Injury, Concussion, Depression, or Addiction
A solution for these conditions that reduces sleep loss or improves sleep quality that affect emotional processing in the brain.

Sleep and Circadian Rhythm
A solution, which better manages age-related physiological or homeostatic regulatory changes of sleep and circadian rhythms (e.g., endocrine, dietary, immune, disease states).

Sleep and Chronic Disease
A solution that helps, improve the quality of life of patients with chronic disease (e.g., obesity, chronic pain, respiratory disease, renal failure, spinal cord injury and heart disease).

Sleep and Life Stages
A solution which offers interventions that reduce impacts of interrupted sleep in newborns, teens, pregnant women, parents, or menopausal women.

COPD Monitoring
A solution which facilitates connectivity to the Internet of Things, allowing for integrated in-home monitoring and data analytics to predict COPD patient outcomes (ex: adherence to therapy, exacerbation of conditions, long-term outcomes, etc.)

Sleep Quality and Performance
A solution which facilitates connectivity to the Internet of Things, allowing for integrated in-home monitoring and data analytics to monitor sleep quality and the overall sleep experience to identify sleep problems and predict outcomes (ex: adherence to therapy, changes in condition, daytime performance etc.)

COPD Management
A solution that improves management of chronic respiratory disease and its acute symptoms (e.g., stranding, stress).

A solution that provides assistive technologies for daily living for individuals with chronic respiratory challenges (e.g., COPD, asthma).
Other elements of interest:
We are also interested in any innovations that include the following technologies. (it is not mandatory that your innovation include one of these)
Interested in innovations that include technology such as:


• Augmented Reality/Virtual Reality
• Gamification (rewards and gratifications)
• Social Integration (integration to social media platforms)
• Machine learning
• Natural Language Processing (NLP)


Evaluation Guidance
OUT OF SCOPE

WE ARE NOT LOOKING FOR SOLUTIONS THAT CONTAIN THE FOLLOWING ELEMENTS:

• Pharmaceutical only solutions
• Hospital only solutions
• FDA Class II requiring a prescription or Class III

SUBMISSIONS MUST CONTAIN:
• Name of principal investigator and all other project team members (note the listed principal investigator must be available to present the project in-person at the LifeScience Futures Confeerence, if the project is selected for presentation)
• Title that clearly and succinctly describes the innovation
• Abstract of no more than 750 words that summarizes the innovation, market opportunity, value proposition, project purpose, goals and objectives, description of how awarded funds will be applied to move the project closer to commercialization.
• Invention disclosure number (if one exists)
Name of Principal Investigator:
*Note: Listed principal investigator must be available to present the project in-person at Life Sciences Future, if the project is selected for presentation

Question Title

* 1. Name of Principal Investigator:
*Note: Listed principal investigator must be available to present the project in-person at Life Sciences Future, if the project is selected for presentation

All other project team members (First, Last, E-mail)

Question Title

* 2. All other project team members (First, Last, E-mail)

Mailing Address:

Question Title

* 3. Mailing Address:


Title that clearly and succinctly describes the innovation:

Question Title

* 4. Title that clearly and succinctly describes the innovation:

Area of Focus:

Question Title

* 5. Area of Focus:

Abstract summarizing the innovation, market opportunity, value proposition, project purpose, goals and objectives and how by accomplishing them the project will move closer to commercialization. (750 word limit)

Question Title

* 6. Abstract summarizing the innovation, market opportunity, value proposition, project purpose, goals and objectives and how by accomplishing them the project will move closer to commercialization. (750 word limit)

Invention disclosure number (if one exists):

Question Title

* 7. Invention disclosure number (if one exists):

Additional Information:

Question Title

* 8. Additional Information:


Companies selected to present will have their presentation deck (non-confidential) reviewed by industry experts in advance of the conference. The committee is composed of 6 experienced life science professionals (including 3 representatives from Philips) across a variety of subject matter areas--biotech, devices, legal, marketing, etc.

Question Title

* 9. Companies selected to present will have their presentation deck (non-confidential) reviewed by industry experts in advance of the conference. The committee is composed of 6 experienced life science professionals (including 3 representatives from Philips) across a variety of subject matter areas--biotech, devices, legal, marketing, etc.



T